Nucleomaxx    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
265脂肪萎縮症1

265. 脂肪萎縮症 [臨床試験数:109,薬物数:164(DrugBank:59),標的遺伝子数:26,標的パスウェイ数:94
Searched query = "Lipodystrophy", "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 109 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00119379
(ClinicalTrials.gov)
April 200511/7/2005Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected AdultsReversibility of Mitochondrial Toxicity in HIV LipoatrophyHIV Infections;Lipodystrophy;Metabolic Diseases;Nutrition DisordersDrug: NucleomaxX;Drug: Tenofovir Disoproxil FumarateNational Institute of Allergy and Infectious Diseases (NIAID)NULLCompleted18 YearsN/AAll50Phase 2United States